Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.

A blood test level of 3.2 ng/mL of Antimüllerian hormone is good for identifying polycystic ovarian morphology in European women aged 25–45.

A pancreatic tumor caused high glucagon levels and symptoms, but treatment reduced glucagon and shrank liver tumors.

Men with certain patterns of hair loss, especially the U pattern, are more likely to develop insulin resistance.

Balding men, especially young ones, may have higher risk of heart issues and diabetes; check cholesterol levels.

PCOS women with COVID-19 have higher cardiometabolic risks.

Gestational diabetes increases risks for mothers and babies, needing early diagnosis and care.

Overweight and obese children in Bangladesh show signs of altered glucose metabolism, indicating a need for screening.

Young men with early hair loss and high SAA3 levels are at higher risk for heart disease.

Insulin resistance may contribute to various skin diseases and treating it could improve skin health and prevent more serious conditions.

Targeted drug delivery to pancreatic beta-cells can improve type 2 diabetes treatment.

Early detection of apolipoprotein levels helps reduce depression risk in the elderly.

Finasteride and dutasteride effectively reduce DHT in hair, which may help evaluate their treatment success for hair loss.

Potassium levels affect blood sugar and insulin during dialysis, and malnutrition changes children's hair roots.

A reliable method was developed to measure aristolochic acid-I in rat blood.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Type 2 diabetes in youth is increasing, with high treatment failure rates and more severe than Type 1; certain drugs can lower lipid levels effectively with varying side effects, and apples may benefit heart health like statins but with fewer side effects.

A new method was created to measure metformin in hair, showing potential for monitoring treatment and medical investigations.

Metformin improved menstrual cycle regularity and signs of hyperandrogenism in adolescent girls with type 1 diabetes but did not improve blood sugar control.

Agalsidase alfa helps treat Fabry's disease but needs more research for long-term benefits.

Combination therapy is better for long-term control and outcomes in type 2 diabetes.

Alopecia areata patients have a higher risk of subclinical atherosclerosis, and carotid ultrasound can help assess their cardiovascular risk.

Using stem cells from hair follicles to treat female hair loss is safe and effective after six months.

People with type 2 diabetes have lower vitamin E levels, especially older adults and females.

SFRP-4 might be an early indicator of diabetes and hypertension in men with androgenic alopecia.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

A girl with type 1 diabetes developed a serious eye condition very early, suggesting the need for earlier eye checks and that early treatment can work well.

Acanthosis nigricans is common in obese individuals, but not significantly linked to obesity type.

The document concludes that HAIR-AN syndrome should be considered when a patient shows severe hyperandrogenism and insulin resistance after excluding tumors.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.